A coalition of 24 states, the District of Columbia, the United States Virgin Islands, and several municipalities has filed suit against the Environmental Protection Agency (EPA) over the agency’s rescission of its 2009 endangerment finding, a foundational regulatory document that classified greenhouse gases as a threat to human health and welfare. The legal challenge represents one of the most consequential environmental and public health disputes to reach federal courts in recent years, with implications that extend well beyond climate policy into the domain of population medicine, respiratory health, and the long-term burden of environmentally attributable disease.

The coalition, led by California and including Connecticut, Massachusetts, and New York among its members, argues that the EPA acted unlawfully when it finalized a rule eliminating the endangerment finding under the direction of the Trump administration. The original 2009 finding, established under the Clean Air Act, obligated the EPA to regulate greenhouse gas emissions from new motor vehicles, among other sources, on the basis that such emissions posed a present and future threat to public health. The agency’s published fact sheet accompanying the rescission characterized the change as prioritizing consumer choice, framing the regulatory reversal as a rejection of what it termed climate change zealotry.

The 2009 Endangerment Finding: A Clinical and Regulatory Foundation

To understand the magnitude of the legal dispute, it is necessary to examine what the 2009 endangerment finding established and why its rescission carries direct consequences for human health outcomes. The finding was predicated on a substantial body of epidemiological and atmospheric science indicating that six greenhouse gases, including carbon dioxide, methane, and nitrous oxide, pose risks to public health through multiple mechanistic pathways.

At the most immediate clinical level, the combustion of fossil fuels that generates these greenhouse gases also produces fine particulate matter (PM2.5) and ground-level ozone, both of which carry well-characterized associations with cardiopulmonary morbidity and mortality. PM2.5 particles, defined as those with aerodynamic diameters of 2.5 micrometers or less, penetrate deep into alveolar tissue, triggering inflammatory cascades that have been linked in longitudinal cohort studies to increased rates of asthma exacerbation, chronic obstructive pulmonary disease (COPD) progression, myocardial infarction, and stroke. Ground-level ozone, generated through photochemical reactions involving nitrogen oxides and volatile organic compounds in the presence of sunlight and heat, is a potent bronchial irritant with particular consequence for pediatric populations and individuals with pre-existing airway disease.

Beyond these acute and subacute mechanisms, the broader greenhouse gas-climate relationship introduces a second tier of health consequences that operate through less direct but no less consequential pathways. Rising mean temperatures extend the geographic and seasonal range of vector-borne infectious diseases, including dengue fever and Lyme disease. Heat-related illness and mortality, particularly among elderly populations and outdoor laborers, represent a growing burden that emergency departments in warm-climate states including Hawaii have begun to document with increasing frequency. Extreme weather events, whose intensification is attributed in the peer-reviewed atmospheric science literature to greenhouse gas accumulation, generate downstream public health crises including physical trauma, displacement, and mental health sequelae including post-traumatic stress disorder and prolonged grief disorders.

Neurological and Psychiatric Dimensions

From a neuroscience perspective, the health consequences of greenhouse gas-driven environmental change extend into domains that clinical medicine has only recently begun to characterize with precision. Ambient air pollution exposure, including PM2.5, has been associated in multiple epidemiological studies with structural and functional alterations in the central nervous system. A 2023 meta-analysis drawing on data from prospective cohort studies across North America, Europe, and East Asia identified statistically significant associations between long-term PM2.5 exposure and accelerated cognitive decline in adults over 60, with effect sizes persisting after adjustment for established confounders including cardiovascular risk factors and socioeconomic status.

Mechanistic work in rodent models has demonstrated that ultrafine particulate matter can cross the blood-brain barrier via olfactory nerve transport and systemic circulation, inducing neuroinflammatory responses characterized by microglial activation and elevated levels of interleukin-6 and tumor necrosis factor-alpha. Whether these preclinical findings translate directly to the human neuroinflammatory context observed in neurodegenerative disease remains an area of active investigation, and the translational gap between animal model data and human neuropathology must be acknowledged with appropriate caution. Nevertheless, the convergence of epidemiological association data and plausible mechanistic pathways has led several major neurology and public health bodies to identify air quality regulation as a component of dementia prevention strategy.

Additionally, the psychiatric health consequences of climate-related disruption have received mounting attention in the literature. Displacement from natural disasters, chronic heat stress, and the psychological burden of environmental loss have been linked to elevated rates of generalized anxiety disorder, major depressive disorder, and in some studied populations, suicidality. For Hawaii specifically, a state whose identity, economy, and cultural continuity are intimately connected to coastal geography, marine ecology, and weather pattern stability, the downstream psychiatric and neurological burden of unchecked greenhouse gas accumulation is not an abstraction.

The Legal Argument and Its Public Health Implications

The states’ legal argument centers on the procedural and substantive requirements of the Clean Air Act, which mandates that EPA regulatory determinations be grounded in the best available science. The coalition contends that the rescission of the endangerment finding was not supported by new scientific evidence that would warrant reversing the 2009 conclusions, but rather reflected a policy preference imposed without adequate scientific or legal justification.

If the courts ultimately sustain the rescission, the practical regulatory consequence would be a substantial reduction in the federal government’s authority and obligation to limit greenhouse gas emissions from motor vehicles, a sector that represents one of the largest sources of such emissions in the United States. The downstream effect on ambient air quality, and by extension on the full spectrum of environmentally attributable disease described above, would depend on the degree to which individual states exercise their own regulatory authority, the pace of voluntary transitions to lower-emission vehicle technologies, and the actions of international trading partners whose own emissions standards influence global atmospheric composition.

California occupies a particular position in this dispute. The state has historically exercised its Clean Air Act waiver authority to set vehicle emission standards more stringent than federal minimums, and numerous other states have adopted California’s standards through the mechanisms the Act provides. Were federal greenhouse gas regulation to be substantially curtailed, the California waiver framework would become the de facto national standard in many jurisdictions, a regulatory architecture that the current federal administration has also moved to challenge through separate administrative actions.

Implications for Hawaii and Pacific Island Health Systems

For clinicians and public health administrators in Hawaii, the litigation carries specific relevance. The state occupies a geography that renders its population acutely sensitive to climate-driven health threats. Sea surface temperature elevation in the central Pacific has intensified hurricane formation and altered precipitation patterns, with documented consequences for drinking water quality, leptospirosis transmission, and vector habitat suitability for dengue-carrying Aedes mosquito species. The Hawaiian archipelago’s relatively constrained land area and the concentration of its population in coastal zones amplify vulnerability to flooding and storm surge events.

Hawaii’s health system has also documented rising rates of heat-related emergency department presentations over the past decade, a trend consistent with regional temperature data showing a measurable upward shift in mean and peak temperatures. Occupational heat exposure among agricultural and construction workers, many of whom belong to communities already experiencing elevated rates of cardiovascular and metabolic disease, represents a clinical priority that local health departments have begun to address through targeted outreach. The regulatory environment governing greenhouse gas emissions at the federal level directly influences the trajectory of these temperature trends.

The Broader Scientific and Regulatory Context

The EPA’s rescission of the endangerment finding occurs at a moment when the scientific consensus on the health consequences of greenhouse gas-driven climate change has, if anything, grown more precise and more alarming in its projections since 2009. Successive assessment reports from the Intergovernmental Panel on Climate Change and domestic equivalents including the National Climate Assessment have refined both the attribution science linking anthropogenic emissions to observed climate changes and the epidemiological characterization of resulting health burdens. The Global Burden of Disease study framework has increasingly incorporated climate-sensitive disease categories, providing quantitative estimates of disability-adjusted life years attributable to climate exposures.

Against this backdrop, the legal challenge mounted by the 24-state coalition functions simultaneously as a test of administrative law principles and as a defense of the scientific evidentiary basis for public health regulation. The outcome of the litigation will determine whether the EPA retains the legal obligation to treat greenhouse gases as a regulated threat to human health under the Clean Air Act, or whether that obligation can be dissolved through executive action without a scientific foundation sufficient to overturn the existing body of evidence.

Federal courts will now be asked to weigh the procedural and substantive adequacy of the rescission rule against the statutory requirements of the Clean Air Act. The duration and trajectory of that legal process remain uncertain. What the existing epidemiological, atmospheric, and mechanistic science literature makes considerably less uncertain is the relationship between greenhouse gas accumulation, ambient air quality, and the health outcomes that